PHOENIX, Sept. 5, 2017 /PRNewswire/ — Amnio Technology, LLC, a leading manufacturer of advanced regenerative allografts derived from human amniotic tissues, announced today the expansion of its product line with the launch of PalinGen® InovōFlo™. PalinGen®...
FOR IMMEDIATE RELEASE: Amnio Technology’s PalinGen® and ProMatrX® Lines Assigned Q Codes for Product Reimbursement Phoenix, AZ, USA (November 14, 2016) – Amnio Technology, LLC, a leading manufacturer of advanced regenerative allografts derived from human amniotic...
FOR IMMEDIATE RELEASE: Amnio Technology Announces PalinGen® and ProMatrX™ Product Coverage by Palmetto GBA Phoenix, AZ, USA (June 15, 2016) – Amnio Technology, a manufacturer and distributor of amnion-derived human allografts, announced today that Palmetto GBA...
Amnio Technology, LLC receives its first US patent for placental tissue allograft Accelular amnion derived therapeutic compositions. Amnion derived materials continue to be evaluated for use in a wide array of clinical conditions. Amnio Technology is dedicated to...
Recent Comments